Immunohistochemical markers of CYP3A4 and CYP3A7: a new tool towards personalized pharmacotherapy of hepatocellular carcinoma

Immunohistochemical markers of CYP3A4 and CYP3A7: a new tool towards personalized pharmacotherapy of hepatocellular carcinoma

<p>Hepatocellular carcinoma (HCC) represents a major global health problem, since more than 90% of primary liver cancers worldwide are HCC. Most cases of HCC are secondary to viral hepatitis infection (hepatitis B or C), alcoholism and cirrhosis. Sorafenib, an oral tyrosine kinase inhibitor th...

Full description

Bibliographic Details
Main Authors: D. Fanni, M. Manchia, F. Lai, C. Gerosa, R. Ambu, G. Faa
Format: Article
Language:English
Published: PAGEPress Publications 2016-04-01
Series:European Journal of Histochemistry
Subjects:
HCC
CYP3A4
CYP3A7
immunohistochemistry
sorafenib.
Online Access:http://www.ejh.it/index.php/ejh/article/view/2614

Internet

http://www.ejh.it/index.php/ejh/article/view/2614

Similar Items